OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ACAD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

ACADIA Pharmaceuticals (ACAD) Earnings Date & Reports

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ACAD is expected to report earnings to fall 16.06% to 13 cents per share on November 11

ACADIA Pharmaceuticals ACAD Stock Earnings Reports

Q3'25

Est.

$0.13

Q2'25

Beat

by $0.02

Q1'25

Beat

by $0.13

Q4'24

Beat

by $0.64

Q3'24

Beat

by $0.06

The last earnings report on August 06 showed earnings per share of 15 cents, beating the estimate of 14 cents. With 313.25K shares outstanding, the current market capitalization sits at 4.15B.

View a ticker or compare two or three

Compare

Search For Dips Search For Dips

Annualized Return+29%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

ACAD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ACAD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACAD showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of pharmaceuticals drugs for treatment of central nervous system disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

12830 El Camino Real

Phone

+1 858 558-2871

Employees

598

Web

https://www.acadia.com